Jeffrey H. Rosedale, Ph.D.
Partner, Woodcock Washburn
Jeff Rosedale is co-chair of both of Woodcock Washburn's nanotechnology and clean-technology patent prosecution and client counseling practice groups. In addition to serving his nanotech and clean-tech clients, Jeff speaks about intellectual property at universities and at nanotech specific industry conferences. He's an active member of the U.S. Patent and Trademark Offices' "Nanotechnology Customer Partnership" and the Nanotechnology subcommittee of the Intellectual Property Owners Association. He's been the session chair and co-organizer of nanotech specific panels for the 2005 and 2006 national meetings of the Biotechnology Industry Organization (BIO), and has spoken at the 2005 Pennsylvania Business of Nanotechnology meetings in Pittsburgh, PA. Jeff is also a co-organizer of the conference on "Commercializing Nanotechnology in Energy Conversion and Storage"; held in November 2005 under the auspices of the New Jersey Technology Council and the Greater Garden State Nanotechnology Alliance.
Jeff Rosedale has come by his proficiency in patent law in a variety of ways. His legal knowledge was enhanced by working as in-house counsel for a Fortune 500 specialty materials manufacturer. His business acumen was sharpened with a certificate in business management from the Wharton School. And his scientific background and fascination with technology is extensive.
Jeff has a Ph.D. in chemical engineering, and has coauthored 18 research articles in a number of international peer-reviewed journals. One of Jeff’s papers, cited more than 250 times, was characterized in Current Opinion in Colloid & Interface Science as "the single paper with the largest impact in the field of block copolymer melt rheology." Culminating in the issuance of four U.S. patents, Jeff's research work – which he began in the mid-1980s at AT&T Bell Laboratories – continues to be referenced today by numerous researchers, many of whom are in the field of nanotechnology.
Jeff's clients have ranged from Fortune 50 multinational corporations for medical devices to entrepreneurial start-ups that seek to commercialize products in the emerging field of nanotechnology. Major universities and federal laboratories also call on Jeff's expertise to protect their innovations in complex technologies. His practice encompasses many disciplines, including chemical and mechanical engineering, chemistry, pharmaceuticals, physics, materials science, optics, chemical and biological analysis, biochemistry, biomedical devices, biotechnology, nanotechnology and bionanotechnology.
|Pharma IP Evergreening Strategies Using Nanotechnology||885.7 KB|